Orai1 contributes to the establishment of an apoptosis-resistant phenotype in prostate cancer cells

Cell Death and Disease

Volumn 1, Issue 9, 2010, Pages

  Flourakis, M ^a,b,f   Lehen'kyi, V ^a,b,f   Beck, B ^a,b,f   Raphael M ^a,b   Vandenberghe, M ^a,b   Abeele, F V ^a,b   Roudbaraki, M ^a,b   Lepage, G ^a,b   Mauroy, B ^c   Romanin, C ^d   Shuba, Y ^e   SkryM A , R ^a,b   Prevarskaya, N ^a,b  

^a Université des Sciences et Technologies de Lille   (France)

^b UNIV LILLE   (France)

^c UNIVERSITÉ CATHOLIQUE DE LILLE   (France)

^d JOHANNES KEPLER UNIVERSITY LINZ   (Austria)

^e BOGOMOLETZ INSTITUTE OF PHYSIOLOGY   (Ukraine)

^f NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Apoptosis resistance; Orai channels; Prostate cancer; Store operated calcium entry

Indexed keywords

CALCIUM ION; CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL 1; CISPLATIN; MESSENGER RNA; OXALIPLATIN; STROMAL INTERACTION MOLECULE 1; THAPSIGARGIN; TUMOR NECROSIS FACTOR ALPHA; ANTINEOPLASTIC AGENT; CALCIUM; CALCIUM CHANNEL; MEMBRANE PROTEIN; ORAI1 PROTEIN, HUMAN; STIM1 PROTEIN, HUMAN; TUMOR PROTEIN;

APOPTOSIS; ARTICLE; CALCIUM TRANSPORT; DOWN REGULATION; HUMAN; HUMAN CELL; MALE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; AMINO ACID SUBSTITUTION; GENETICS; METABOLISM; MUTATION; PHYSIOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

AMINO ACID SUBSTITUTION; ANTINEOPLASTIC AGENTS; APOPTOSIS; CALCIUM; CALCIUM CHANNELS; CELL LINE, TUMOR; CISPLATIN; HUMANS; MALE; MEMBRANE PROTEINS; MUTATION; NEOPLASM PROTEINS; PHENOTYPE; PROSTATIC NEOPLASMS; THAPSIGARGIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79958284668     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2010.52     Document Type: Article

References (32)

1. Scorrano L, Oakes SA, Opferman JT, Cheng EH, Sorcinelli MD, Pozzan T et al. BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis. Science 2003; 300: 135-139. (Pubitemid 36423046)
2. Prevarskaya N, Skryma R, Shuba Y. Ca2+ homeostasis in apoptotic resistance of prostate cancer cells. Biochem Biophys Res Commun 2004; 322: 1326-1335. (Pubitemid 39164661)
3. Pinton P, Giorgi C, Siviero R, Zecchini E, Rizzuto R. Calcium and apoptosis: ERmitochondria Ca2+ transfer in the control of apoptosis. Oncogene 2008; 27: 6407-6418.
4. Norberg E, Gogvadze V, Ott M, Horn M, Uhlen P, Orrenius S et al. An increase in intracellular Ca2+ is required for the activation of mitochondrial calpain to release AIF during cell death. Cell Death Differ 2008; 15: 1857-1864.
5. Fixemer T, Remberger K, Bonkhoff H. Apoptosis resistance of neuroendocrine phenotypes in prostatic adenocarcinoma. Prostate 2002; 53: 118-123.
6. Raffo AJ, Perlman H, Chen MW, Day ML, Streitman JS, Buttyan R. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res 1995; 55: 4438-4445.
7. Tannock IF, de Wit R, Berry WR, Horti J, Pluzanska A, Chi KN et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 2004; 351: 1502-1512. (Pubitemid 39315317)
8. Skryma R, Mariot P, Bourhis XL, Coppenolle FV, Shuba Y, Vanden Abeele F et al. Store depletion and store-operated Ca2+ current in human prostate cancer LNCaP cells: involvement in apoptosis. J Physiol 2000; 527 (Pt 1): 71-83. (Pubitemid 30649585)
9. Vanoverberghe K, Vanden Abeele F, Mariot P, Lepage G, Roudbaraki M, Bonnal JL et al. Ca2+ homeostasis and apoptotic resistance of neuroendocrine-differentiated prostate cancer cells. Cell Death Differ 2004; 11: 321-330. (Pubitemid 38313141)
10. Zhang SL, Yu Y, Roos J, Kozak JA, Deerinck TJ, Ellisman MH et al. STIM1 is a Ca2+ sensor that activates CRAC channels and migrates from the Ca2+ store to the plasma membrane. Nature 2005; 437: 902-905. (Pubitemid 41486767)
11. Liao Y, Erxleben C, Yildirim E, Abramowitz J, Armstrong DL, Birnbaumer L. Orai proteins interact with TRPC channels and confer responsiveness to store depletion. Proc Natl Acad Sci USA 2007; 104: 4682-4687. (Pubitemid 47186285)
12. Muik M, Frischauf I, Derler I, Fahrner M, Bergsmann J, Eder P et al. Dynamic coupling of the putative coiled-coil domain of ORAI1 with STIM1 mediates ORAI1 channel activation. J Biol Chem 2008; 283: 8014-8022.
13. Ng SW, di Capite J, Singaravelu K, Parekh AB. Sustained activation of the tyrosine kinase Syk by antigen in mast cells requires local Ca2+ influx through Ca2+ release-activated Ca2+ channels. J Biol Chem 2008; 283: 31348-31355.
14. Vanden Abeele F, Skryma R, Shuba Y, Van Coppenolle F, Slomianny C, Roudbaraki M et al. Bcl-2-dependent modulation of Ca(2+) homeostasis and store-operated channels in prostate cancer cells. Cancer Cell 2002; 1: 169-179. (Pubitemid 41039163)
15. Abdullaev F, Bludov YV, Dmitriev SV, Kevrekidis PG, Konotop VV. Generalized neighborinteraction models induced by nonlinear lattices. Phys Rev E Stat Nonlin Soft Matter Phys 2008; 77 (Pt 2): 016604.
16. Gwack Y, Feske S, Srikanth S, Hogan PG, Rao A. Signalling to transcription: store-operated Ca(2+) entry and NFAT activation in lymphocytes. Cell Calcium 2007; 42: 145-156. (Pubitemid 47029605)
17. Stiber J, Hawkins A, Zhang ZS, Wang S, Burch J, Graham V et al. STIM1 signalling controls store-operated calcium entry required for development and contractile function in skeletal muscle. Nat Cell Biol 2008; 10: 688-697. (Pubitemid 351772934)
18. Denmeade SR, Lin XS, Isaacs JT. Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer. Prostate 1996; 28: 251-265. (Pubitemid 26119117)
19. Bonkhoff H. Neuroendocrine differentiation in human prostate cancer. Morphogenesis, proliferation and androgen receptor status. Ann Oncol 2001; 12: S141-S144. (Pubitemid 33069704)
20. Nantermet PV, Xu J, Yu Y, Hodor P, Holder D, Adamski S et al. Identification of genetic pathways activated by the androgen receptor during the induction of proliferation in the ventral prostate gland. J Biol Chem 2004; 279: 1310-1322. (Pubitemid 38082656)
21. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A et al. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 2005; 21: 2933-2942. (Pubitemid 40916416)
22. Denmeade SR, Isaacs JT. The SERCA pump as a therapeutic target: making a 'smart bomb' for prostate cancer. Cancer Biol Ther 2005; 4: 14-22. (Pubitemid 41350924)
23. Gonzalez VM, Fuertes MA, Alonso C, Perez JM. Is cisplatin-induced cell death always produced by apoptosis? Mol Pharmacol 2001; 59: 657-663. (Pubitemid 32273993)
24. Di Sano F, Ferraro E, Tufi R, Achsel T, Piacentini M, Cecconi F. Endoplasmic reticulum stress induces apoptosis by an apoptosome-dependent but caspase 12-independent mechanism. J Biol Chem 2006; 281: 2693-2700. (Pubitemid 43845732)
25. Nawrocki ST, Carew JS, Dunner Jr K, Boise LH, Chiao PJ, Huang P et al. Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells. Cancer Res 2005; 65: 11510-11519. (Pubitemid 41821709)
26. Flourakis M, Van Coppenolle F, Lehen'kyi V, Beck B, Skryma R, Prevarskaya N. Passive calcium leak via translocon is a first step for iPLA2-pathway regulated store operated channels activation. FASEB J 2006; 20: 1215-1217.
27. Peinelt C, Vig M, Koomoa DL, Beck A, Nadler MJ, Koblan-Huberson M et al. Amplification of CRAC current by STIM1 and CRACM1 (Orai1). Nat Cell Biol 2006; 8: 771-773.
28. Yang S, Zhang JJ, Huang XY. Orai1 and STIM1 are critical for breast tumor cell migration and metastasis. Cancer Cell 2009; 15: 124-134.
29. Potier M, Gonzalez JC, Motiani RK, Abdullaev IF, Bisaillon JM, Singer HA et al. Evidence for STIM1- and Orai1-dependent store-operated calcium influx through ICRAC in vascular smooth muscle cells: role in proliferation and migration. FASEB J 2009; 23: 2425-2437.
30. Smyth JT, Petranka JG, Boyles RR, DeHaven WI, Fukushima M, Johnson KL et al. Phosphorylation of STIM1 underlies suppression of store-operated calcium entry during mitosis. Nat Cell Biol 2009; 11: 1465-1472.
31. Lehen'kyi V, Flourakis M, Skryma R, Prevarskaya N. TRPV6 channel controls prostate cancer cell proliferation via Ca(2+)/NFAT-dependent pathways. Oncogene 2007; 26: 7380-7385. (Pubitemid 350115979)
32. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402-408. (Pubitemid 34164012)